Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies. Hetero has launched its generic semaglutide portfolio in
Ultra-low dose of cancer meds works, reduces costs by 90%, finds Tata studyThe Parel-based premier cancer hospital found that giving one-tenth of the standard dosage
The eagerly anticipated semaglutide patent cliff in India has unleashed a strikingly varied pricing landscape. The intensity of the price decline is driven by the
New Delhi: Medicine prices in India may rise sharply amid a 30% surge in the cost of key raw materials or active pharma ingredients in
With the patent protection for Novo Nordisk’s best-selling medicine semaglutide expiring in India, at least eight Indian companies on Saturday launched cheaper, generic versions of
Hyderabad-based Natco Pharma has launched its generic semaglutide injection in India at a starting price of Rs 1,290 per month, marking one of the cheapest
Mumbai: Doctors in India are increasingly testing “dose optimisation” to make high-cost treatments affordable while cutting side-effects, and Tata Memorial Hospital’s latest findings underline how
As India enters 2026, its medical devices sector stands at an inflection point. The convergence of targeted manufacturing incentives, regulatory consolidation, and sustained healthcare demand
Drug resistance is outpacing industrywide efforts, says Netherlandsbased Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven
Dr Reddy’s Laboratories is strategically shifting focus towards biosimilars and innovation. The company is increasing investment in biosimilars, anticipating significant growth within five years. Generics
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump